Pioglitazone versus Rosiglitazone: Effects on Lipids, Lipoproteins, and Apolipoproteins in Head-to-Head Randomized Clinical Studies
Peroxisome proliferator-activated receptors (PPARs) play an important role in regulating both glucose and lipid metabolism. Agonists for both PPAR𝛾 and PPAR𝛾 have been used to treat dyslipidemia and hyperglycemia, respectively. In addition to affecting glucose metabolism, PPAR𝛾 agonists also regul...
Saved in:
Main Authors: | Mark A. Deeg, Meng H. Tan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2008-01-01
|
Series: | PPAR Research |
Online Access: | http://dx.doi.org/10.1155/2008/520465 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Simultaneous Estimation of Glimepiride, Rosiglitazone and Pioglitazone Hydrochloride in the Pharmaceutical Dosage Form
by: Freddy H. Havaldar, et al.
Published: (2010-01-01) -
Rosiglitazone and Pioglitazone Alter Aromatase Kinetic Properties in Human Granulosa Cells
by: Takako Araki, et al.
Published: (2011-01-01) -
Alendronate versus Raloxifene for Postmenopausal Women: A Meta-Analysis of Seven Head-to-Head Randomized Controlled Trials
by: Tiao Lin, et al.
Published: (2014-01-01) -
Effects and Potential Mechanisms of Pioglitazone on Lipid Metabolism in Obese Diabetic KKAy Mice
by: Jun Peng, et al.
Published: (2014-01-01) -
Effectiveness of Head MSCT Examination in Cases of Mild Head Injuries
by: Dyah Ayu Puspitaningtyas, et al.
Published: (2025-01-01)